# Rapid Response Central: Detailed Protocol Appendix
## Comprehensive Evidence-Based Clinical Guidelines

---

## Table of Contents

### Primary Protocols
1. [Cardiovascular Emergencies](#cardiovascular-emergencies)
2. [Respiratory Emergencies](#respiratory-emergencies)
3. [Neurological Emergencies](#neurological-emergencies)
4. [Shock States](#shock-states)
5. [Metabolic Emergencies](#metabolic-emergencies)
6. [Hematologic Emergencies](#hematologic-emergencies)
7. [Gastrointestinal Emergencies](#gastrointestinal-emergencies)
8. [Renal Emergencies](#renal-emergencies)
9. [Infectious Disease Emergencies](#infectious-disease-emergencies)
10. [Toxicology](#toxicology)

---

## Cardiovascular Emergencies

### Acute Coronary Syndrome
[← Back to Main ACS](#acute-coronary-syndrome)

#### STEMI Protocol

**Diagnostic Criteria:**
- ST elevation ≥1mm in ≥2 contiguous leads (except V2-V3)
- V2-V3: ≥2mm in men ≥40y, ≥2.5mm in men <40y, ≥1.5mm in women
- New LBBB with clinical presentation consistent with ACS

**Door-to-Device Checklist:**
- [ ] ECG within 10 minutes of arrival
- [ ] Cath lab activated within 20 minutes
- [ ] Aspirin 324mg chewed given
- [ ] P2Y12 inhibitor loaded
- [ ] Anticoagulation started
- [ ] Beta-blocker given (if appropriate)
- [ ] Patient on cath lab table <90 minutes

**Contraindications to Primary PCI:**
- Unable to access within 120 minutes
- Patient refuses
- Extensive comorbidities with limited life expectancy

**Fibrinolysis Protocol (if PCI unavailable):**
1. **Inclusion:** STEMI <12h onset, PCI unavailable in 120min
2. **Absolute contraindications:**
   - Prior intracranial hemorrhage
   - Ischemic stroke <3 months
   - Suspected aortic dissection
   - Active bleeding
3. **Medication:** Tenecteplase (weight-based) or Alteplase
4. **Success markers:** >50% ST resolution at 90min

**Post-PCI Management:**
- Dual antiplatelet x12 months
- High-intensity statin
- ACE-I/ARB
- Beta-blocker
- Aldosterone antagonist if EF <40%

**Mechanical Complications:**
- [→ Free wall rupture](#free-wall-rupture) (Days 3-5)
- [→ VSD](#ventricular-septal-defect) (Days 3-5)
- [→ Papillary muscle rupture](#papillary-muscle-rupture) (Days 2-7)

#### NSTEMI/UA Protocol

**High-Risk Features (early invasive <24h):**
- GRACE score >140
- Troponin rise/fall
- Dynamic ST/T changes
- Refractory angina
- Heart failure
- Hemodynamic instability
- Sustained VT
- Prior CABG/PCI

**Medical Management:**
```
Antiplatelet:
├── Aspirin 162-325mg → 81mg daily
├── P2Y12 inhibitor:
│   ├── Ticagrelor 180mg → 90mg BID (preferred)
│   ├── Prasugrel 60mg → 10mg daily (if PCI)
│   └── Clopidogrel 600mg → 75mg daily
└── Consider GPIIb/IIIa if high thrombus burden

Anticoagulation:
├── UFH: 60 U/kg bolus → 12 U/kg/hr
├── Enoxaparin: 1mg/kg SC BID
└── Fondaparinux: 2.5mg SC daily
```

### Atrial Fibrillation

**Rate Control Targets:**
- Resting HR <110 (lenient)
- Resting HR <80 (strict, if symptoms persist)

**Acute Rate Control:**
| Drug | Loading Dose | Maintenance | Contraindications |
|------|-------------|-------------|-------------------|
| Metoprolol | 5mg IV q5min x3 | 25-100mg PO BID | Decompensated HF, bradycardia |
| Diltiazem | 0.25mg/kg IV → 0.35mg/kg | 5-15mg/hr infusion | Severe LV dysfunction |
| Digoxin | 0.5mg IV → 0.25mg q6h x2 | 0.125-0.25mg daily | Renal failure, AV block |
| Amiodarone | 150mg IV over 10min | 1mg/min x6h → 0.5mg/min | Thyroid disease, lung disease |

**Rhythm Control - Cardioversion:**
1. **If AF <48 hours:** Proceed with cardioversion
2. **If AF >48 hours or unknown:**
   - TEE to rule out LAA thrombus OR
   - Anticoagulate x3 weeks → cardiovert → continue x4 weeks
3. **Electrical:** Synchronized 120-200J biphasic
4. **Chemical:** 
   - Ibutilide 1mg IV over 10min (may repeat x1)
   - Flecainide 300mg PO (if no structural disease)

**CHA2DS2-VASc Scoring:**
- C: CHF/LV dysfunction (1)
- H: Hypertension (1)
- A2: Age ≥75 (2)
- D: Diabetes (1)
- S2: Stroke/TIA/TE (2)
- V: Vascular disease (1)
- A: Age 65-74 (1)
- Sc: Sex category female (1)

**Score ≥2 men, ≥3 women → Anticoagulation**

### Ventricular Tachycardia

**Stable VT Management:**
1. **Amiodarone:** 150mg IV over 10min → 1mg/min
2. **Procainamide:** 17mg/kg at 20-50mg/min
3. **Synchronized cardioversion** if medication fails

**Unstable VT → Immediate synchronized cardioversion**

**VT Storm (≥3 episodes in 24h):**
- Beta-blockade (esmolol infusion)
- Amiodarone infusion
- Correct electrolytes (K+ >4.0, Mg2+ >2.0)
- Consider sedation/intubation
- EP consultation for ablation

### Aortic Dissection

**Stanford Classification:**
- **Type A:** Involves ascending aorta → Surgical emergency
- **Type B:** Descending only → Medical management

**Immediate Management:**
1. **Pain control:** Morphine (avoid cocaine-induced)
2. **HR control:** Target HR <60
   - Esmolol infusion (preferred)
   - Labetalol 20mg IV → 40-80mg q10min
3. **BP control:** Target SBP 100-120
   - Add nitroprusside after beta-blockade
4. **Imaging:** CTA chest/abdomen/pelvis
5. **Surgical consultation** for Type A

**Complications to monitor:**
- Aortic regurgitation
- Cardiac tamponade
- Myocardial ischemia (coronary involvement)
- Stroke (carotid involvement)
- Mesenteric ischemia
- Renal failure
- Limb ischemia

---

## Respiratory Emergencies

### COPD Exacerbation

**Severity Assessment:**
| Mild | Moderate | Severe | Life-threatening |
|------|----------|---------|------------------|
| ↑ SOB | ↑ SOB + wheeze | Marked ↑ SOB | Exhaustion |
| RR <24 | RR 24-30 | RR >30 | Paradoxical chest |
| No accessory muscles | Using accessories | Using accessories | Silent chest |
| Speaks sentences | Speaks phrases | Speaks words | Unable to speak |

**Management Algorithm:**
```
Initial Treatment:
├── O2 therapy → Target 88-92%
├── Bronchodilators:
│   ├── Albuterol 2.5mg + ipratropium 0.5mg neb q20min x3
│   └── Then q2-4h
├── Steroids:
│   ├── Prednisone 40mg PO daily x5 days OR
│   └── Methylprednisolone 125mg IV if unable to take PO
└── Antibiotics if ≥2 of:
    ├── ↑ Dyspnea
    ├── ↑ Sputum volume
    └── ↑ Sputum purulence
```

**BiPAP Indications:**
- pH <7.35 with pCO2 >45
- Moderate-severe dyspnea with accessory muscle use
- RR >25
- Failed initial medical therapy

**BiPAP Settings:**
- Start IPAP 10, EPAP 5
- Titrate IPAP by 2 q5-15min for tidal volume 6-8mL/kg
- Max IPAP 20-25

### Asthma Exacerbation

**Severity Classification:**

| Parameter | Mild | Moderate | Severe | Life-threatening |
|-----------|------|----------|---------|------------------|
| PEF | >70% | 40-70% | <40% | <25% |
| O2 sat | >95% | 91-95% | <91% | <91% + cyanosis |
| Speech | Sentences | Phrases | Words | Unable |
| Alertness | May be agitated | Agitated | Agitated | Drowsy/confused |

**Treatment Protocol:**
1. **Immediate:**
   - O2 to maintain sat >94%
   - Albuterol 2.5-5mg neb continuous
   - Ipratropium 0.5mg neb q20min x3
   - Methylprednisolone 125mg IV or prednisone 60mg PO

2. **If not improving after 1 hour:**
   - Magnesium sulfate 2g IV over 20min
   - Consider epinephrine 0.3mg IM (1:1000)
   - Consider heliox

3. **Refractory/near arrest:**
   - Ketamine 0.5-2mg/kg IV
   - Consider ECMO

**Discharge Criteria:**
- PEF >70% predicted
- O2 sat >94% on room air
- Minimal symptoms
- Adequate medications/follow-up

### Pulmonary Embolism

**Risk Stratification Tools:**

**Wells Criteria:**
- Clinical signs of DVT (3)
- PE as likely as alternative diagnosis (3)
- HR >100 (1.5)
- Immobilization/surgery past 4 weeks (1.5)
- Previous DVT/PE (1.5)
- Hemoptysis (1)
- Malignancy (1)

**Score interpretation:**
- ≤4: PE unlikely → D-dimer
- >4: PE likely → CTA

**PESI Score for mortality:**
[→ PESI Calculator](#pesi-calculator)

**Treatment by Risk:**

**High Risk (Massive):**
1. **Systemic thrombolysis:**
   - Alteplase 100mg IV over 2h OR
   - Tenecteplase weight-based bolus
2. **Contraindications to lytics:**
   - Catheter-directed therapy
   - Surgical embolectomy
   - ECMO as bridge

**Intermediate-High Risk:**
- Consider reduced-dose tPA (50mg over 2h)
- Close monitoring in ICU
- Escalate if deteriorates

**Anticoagulation Options:**
- UFH: 80 U/kg bolus → 18 U/kg/hr (preferred if unstable)
- LMWH: Enoxaparin 1mg/kg SC BID
- DOAC: Rivaroxaban 15mg PO BID x21d → 20mg daily

### Pneumothorax

**Size Estimation (Light's criteria):**
- % pneumothorax = 100 - (100 × DL³/DH³)
- DL = lung diameter, DH = hemithorax diameter

**Management by Type:**

**Primary Spontaneous:**
- Small (<2cm) + asymptomatic → Observe
- Large (>2cm) or symptomatic → Aspiration
- Failed aspiration → Chest tube

**Secondary Spontaneous:**
- Small (1-2cm) + minimal symptoms → Aspiration
- Large (>2cm) or symptomatic → Chest tube
- All require admission

**Tension Pneumothorax:**
- Immediate needle decompression (2nd ICS MCL)
- Followed by chest tube

**Chest Tube Management:**
- Size: 14-22 Fr for pneumothorax
- Position: 4th-5th ICS anterior axillary line
- Suction: -20 cmH2O
- Removal: No air leak x24h + lung expanded

---

## Neurological Emergencies

### Stroke/TIA

**NIH Stroke Scale:**
[→ Interactive NIHSS Calculator](#nihss)

**Acute Ischemic Stroke Timeline:**
```
0-3 hours:
├── IV tPA if eligible
├── Consider endovascular if LVO
└── Aspirin if tPA contraindicated

3-4.5 hours:
├── IV tPA with additional exclusions
└── Endovascular for LVO

4.5-24 hours:
├── Endovascular if:
│   ├── LVO present
│   ├── NIHSS ≥6
│   └── Mismatch on perfusion imaging
└── Aspirin + statin if no intervention
```

**tPA Inclusion Criteria:**
- Clinical diagnosis of ischemic stroke
- Measurable neurologic deficit
- Symptom onset <4.5 hours

**tPA Exclusion Criteria:**

**Absolute:**
- ICH on CT
- Previous ICH
- Ischemic stroke within 3 months
- Severe head trauma within 3 months
- Intracranial neoplasm
- GI/GU hemorrhage within 21 days
- Intracranial/spinal surgery within 3 months
- Aortic dissection
- Active bleeding

**Relative (3-4.5h window):**
- Age >80
- NIHSS >25
- Any anticoagulant use
- History of stroke + diabetes

**Blood Pressure Management:**

**Pre-tPA:**
- Treat if >185/110
- Labetalol 10-20mg IV
- Nicardipine infusion 5mg/hr

**Post-tPA:**
- Maintain <180/105
- Check q15min x2h, then q30min x6h, then q1h x16h

**Hemorrhagic Transformation:**
- Occurs in 6-20% post-tPA
- Stop tPA, get STAT head CT
- Type & cross, check fibrinogen
- Cryoprecipitate 10 units
- Consider aminocaproic acid

### Status Epilepticus

**Time-based Treatment Protocol:**

**0-5 minutes:**
- Secure airway, O2, IV access
- Check glucose, give thiamine 100mg IV
- Lorazepam 4mg IV (may repeat x1) OR
- Midazolam 10mg IM if no IV

**5-20 minutes:**
- Load with ONE of:
  - Fosphenytoin 20mg PE/kg at 150mg/min
  - Valproate 40mg/kg at 6mg/kg/min
  - Levetiracetam 60mg/kg (max 4500mg) over 15min

**20-40 minutes (refractory):**
- Intubate
- Choose ONE:
  - Propofol 2mg/kg → 200mcg/kg/min
  - Midazolam 0.2mg/kg → 0.1-2mg/kg/hr
  - Pentobarbital 5mg/kg → 1-5mg/kg/hr
- Goal: Burst suppression on EEG

**>40 minutes (super-refractory):**
- Consider ketamine 1-5mg/kg → 1-10mg/kg/hr
- Evaluate for autoimmune causes
- Consider hypothermia

### Meningitis/Encephalitis

**Empiric Antibiotics (give within 1 hour):**

| Age/Risk | Regimen |
|----------|---------|
| 18-50 years | Ceftriaxone 2g IV q12h + Vancomycin 15-20mg/kg IV q8-12h |
| >50 or immunocompromised | Above + Ampicillin 2g IV q4h |
| Neurosurgery/trauma/shunt | Vancomycin + Cefepime or Meropenem |

**Add Dexamethasone 10mg IV q6h x4 days if:**
- Pneumococcal meningitis suspected
- Give with or before first antibiotic dose

**Add Acyclovir 10mg/kg IV q8h if:**
- Encephalitis suspected
- Immunocompromised
- HSV risk factors

**LP Interpretation:**

| Parameter | Bacterial | Viral | TB/Fungal |
|-----------|-----------|-------|-----------|
| WBC | >1000 (PMN) | <1000 (lymph) | Variable |
| Protein | >150 | 50-150 | >150 |
| Glucose | <40 | Normal | <40 |
| CSF:serum glucose | <0.4 | >0.6 | <0.4 |

---

## Shock States

### Septic Shock

**2024 Surviving Sepsis Campaign Updates:**

**Recognition:**
- Suspected infection + organ dysfunction
- MAP <65 despite fluids
- Lactate >2 mmol/L

**Management Bundles:**

**First Hour:**
1. Lactate measurement
2. Blood cultures before antibiotics
3. Broad-spectrum antibiotics
4. 30mL/kg crystalloid for hypotension/lactate ≥4
5. Vasopressors for MAP ≥65

**Antibiotic Selection by Source:**

| Source | First-line Coverage |
|--------|-------------------|
| Unknown | Vancomycin + Piperacillin-tazobactam |
| Pneumonia | Ceftriaxone + Azithromycin ± Vancomycin |
| UTI | Ceftriaxone or Fluoroquinolone |
| Abdominal | Piperacillin-tazobactam or Carbapenem |
| Skin/Soft tissue | Vancomycin + Piperacillin-tazobactam |
| Meningitis | Ceftriaxone + Vancomycin + Ampicillin |

**Vasopressor Algorithm:**
```
MAP <65 after fluids
├── Norepinephrine (first-line)
│   └── Start 0.05 mcg/kg/min
│       └── Titrate to MAP ≥65
├── If Norepi >0.25 mcg/kg/min
│   └── Add Vasopressin 0.03 units/min
└── If still hypotensive
    ├── Add Epinephrine 0.05-0.3 mcg/kg/min
    └── Consider Hydrocortisone 200mg/day
```

**Special Considerations:**
- ScvO2 monitoring no longer recommended
- Procalcitonin to guide antibiotic duration
- Consider ECMO for refractory shock

### Cardiogenic Shock

**SCAI Shock Classification:**
- A: At risk (ACS, decompensated HF)
- B: Beginning (hypotension without hypoperfusion)
- C: Classic (hypoperfusion requiring intervention)
- D: Deteriorating (failing initial interventions)
- E: Extremis (cardiac arrest, ECMO)

**Management by Stage:**

**Stage B:**
- Optimize volume status
- Diuresis if overloaded
- Inotrope if low output

**Stage C:**
- Invasive hemodynamics (PA catheter)
- Inotrope selection:
  - Dobutamine 2.5-20 mcg/kg/min (first-line)
  - Milrinone 0.125-0.75 mcg/kg/min (if on beta-blocker)
- Add vasopressor if hypotensive:
  - Norepinephrine (preferred)
  - Avoid dopamine (↑ mortality)

**Stage D/E:**
- Mechanical circulatory support:
  - IABP (limited benefit)
  - Impella
  - VA-ECMO
  - Consider LVAD/transplant

**Monitoring:**
- Cardiac index >2.2 L/min/m²
- PCWP 15-18 mmHg
- SVR 800-1200 dynes
- Mixed venous O2 >65%

### Anaphylaxis

**Diagnostic Criteria (≥1 of):**
1. Acute skin/mucosal involvement + respiratory or cardiovascular symptoms
2. Two or more after allergen exposure:
   - Skin/mucosal symptoms
   - Respiratory symptoms
   - Cardiovascular symptoms
   - GI symptoms
3. Hypotension after known allergen exposure

**Treatment Algorithm:**
```
IMMEDIATE:
├── Remove trigger
├── Epinephrine 0.3-0.5mg IM (lateral thigh)
│   └── Repeat q5-15min PRN
├── High-flow O2
├── Large bore IV x2
└── Continuous monitoring

SECONDARY:
├── NS 1-2L bolus
├── H1 blocker: Diphenhydramine 50mg IV
├── H2 blocker: Famotidine 20mg IV
├── Steroid: Methylprednisolone 125mg IV
└── Albuterol for bronchospasm

REFRACTORY:
├── Epinephrine infusion 0.1 mcg/kg/min
├── Consider glucagon 1-5mg IV if on beta-blocker
└── Consider methylene blue for vasoplegia
```

**Biphasic Reaction Prevention:**
- Observe 4-6 hours minimum
- 24 hours if severe reaction
- Discharge with epinephrine auto-injector
- Prednisone 50mg daily x3 days

---

## Metabolic Emergencies

### DKA (Diabetic Ketoacidosis)

**Diagnostic Criteria:**
- Glucose >250 mg/dL
- pH <7.3 or HCO3 <18
- Ketones in blood/urine
- Anion gap >10

**Management Protocol:**

**1. Fluids:**
```
0.9% NS 1L/hr x2
├── If corrected Na normal/high → 0.45% NS
├── If corrected Na low → Continue 0.9% NS
└── Add dextrose when glucose <250
```

**2. Insulin:**
- Bolus: 0.1 units/kg IV (optional)
- Infusion: 0.1 units/kg/hr
- ↓ by 50% when glucose <250
- Continue until anion gap closed

**3. Potassium:**
- K+ <3.3: Hold insulin, give 20-30 mEq/hr
- K+ 3.3-5.2: Give 20-30 mEq per liter
- K+ >5.2: No supplement

**4. Bicarbonate:**
- Only if pH <6.9
- 100 mEq in 400mL H2O + 20 mEq KCl over 2 hours

**Resolution Criteria:**
- Glucose <200
- Anion gap <12
- Bicarbonate >15
- Able to eat

**Transition to SubQ Insulin:**
- Give long-acting insulin 2 hours before stopping infusion
- Calculate total daily dose: 0.5-0.8 units/kg

### HHS (Hyperosmolar Hyperglycemic State)

**Diagnostic Criteria:**
- Glucose >600 mg/dL
- Osmolality >320 mOsm/kg
- pH >7.3
- Minimal ketones

**Key Differences from DKA:**
- More volume depletion (8-10L deficit)
- Higher mortality
- Risk of thrombosis
- Slower correction needed

**Management:**
- Fluids: 1-1.5L/hr initially (monitor for overload)
- Insulin: Half the DKA rate (0.05 units/kg/hr)
- Goal glucose reduction: 50-75 mg/dL/hr
- Anticoagulation prophylaxis

### Hypoglycemia

**Treatment by Severity:**

**Mild (able to self-treat):**
- 15-20g oral glucose
- Recheck in 15 minutes

**Moderate (needs assistance):**
- D50 25-50mL IV OR
- Glucagon 1mg IM/SC

**Severe (unconscious/seizing):**
- D50 50-100mL IV
- Glucagon 1mg IM if no IV
- Consider hydrocortisone 100mg IV

**Special Populations:**
- Sulfonylurea: Octreotide 50mcg SC q6h
- Beta-blocker: Glucagon 3-5mg IV
- Insulinoma: Diazoxide, frequent feeds

### Electrolyte Emergencies

#### Hyperkalemia
[← Back to Lab Triggers](#hyperkalemia)

**ECG Progression:**
- 5.5-6.5: Peaked T waves
- 6.5-7.5: PR prolongation, flat P
- 7.5-8.5: Wide QRS
- >8.5: Sine wave → VF

**Treatment Priority:**
1. Stabilize: Ca-gluconate 10% 10mL IV
2. Shift: Insulin/glucose, albuterol, bicarb
3. Remove: Diuretics, K-binders, dialysis

#### Hyponatremia

**Classification:**
- Mild: 130-135
- Moderate: 125-129
- Severe: <125

**Symptomatic Hyponatremia:**
- 3% saline 100mL over 10min
- Repeat up to 3x if seizing
- Goal: ↑ 4-6 mEq/L acutely

**Correction Limits:**
- <10-12 mEq/L in 24h
- <18 mEq/L in 48h
- Risk: Osmotic demyelination

**Workup:**
```
Serum osmolality
├── <280: True hyponatremia
│   └── Check urine osmolality
│       ├── <100: Primary polydipsia
│       └── >100: Check volume status
│           ├── Hypovolemic: Check UNa
│           ├── Euvolemic: SIADH, hypothyroid
│           └── Hypervolemic: CHF, cirrhosis
└── >280: Pseudohyponatremia
```

#### Hypercalcemia

**Symptoms by Level:**
- 11-12: Often asymptomatic
- 12-13: Weakness, constipation
- 13-14: Confusion, polyuria
- >14: Coma, cardiac arrest

**Acute Management:**
1. NS 200-300mL/hr (3-6L/day)
2. Calcitonin 4 units/kg SC q12h
3. Bisphosphonate (after hydration):
   - Zoledronic acid 4mg IV
   - Pamidronate 60-90mg IV
4. Consider hemodialysis if >18 or symptomatic

**Treat Underlying Cause:**
- PTH high → Primary hyperparathyroidism
- PTH low → Malignancy, check PTHrP
- Consider: Vitamins A/D, thiazides, lithium

---

## Hematologic Emergencies

### Massive Transfusion Protocol

**Activation Criteria:**
- ≥10 units PRBCs in 24h expected
- ≥4 units in 1 hour
- Replacement of entire blood volume

**1:1:1 Resuscitation:**
- 6 units PRBCs
- 6 units FFP
- 1 unit platelets

**Additional Components:**
- Cryoprecipitate if fibrinogen <150
- Factor VIIa for refractory bleeding
- TXA 1g over 10min → 1g over 8h

**Monitoring:**
- CBC, PT/INR, fibrinogen q30-60min
- TEG/ROTEM if available
- Ionized calcium (citrate toxicity)

### Sickle Cell Crisis

**Vaso-occlusive Crisis:**
1. Pain control:
   - Morphine 0.1mg/kg IV q2-3h
   - PCA if frequent doses
   - NSAIDs if no contraindication
2. Hydration: NS at 1.5x maintenance
3. O2 only if hypoxic
4. Incentive spirometry
5. DVT prophylaxis

**Acute Chest Syndrome:**
- CXR: New infiltrate + fever/respiratory symptoms
- Empiric antibiotics (ceftriaxone + azithromycin)
- Exchange transfusion if:
  - O2 sat <90% despite O2
  - Rapid progression
  - Multi-lobar involvement

**Aplastic Crisis:**
- Parvovirus B19 common trigger
- Severe anemia without reticulocytosis
- Simple transfusion to Hgb 7-9

### TTP/HUS

**Pentad (all 5 rare):**
1. Microangiopathic hemolytic anemia
2. Thrombocytopenia
3. Renal failure
4. Fever
5. Neurologic symptoms

**Diagnosis:**
- Schistocytes on smear
- ↑ LDH, ↓ haptoglobin
- Normal PT/PTT
- ADAMTS13 <10% (TTP)

**Treatment:**
- Plasma exchange ASAP (within 4-8 hours)
- Steroids: Methylprednisolone 1g IV daily x3
- Rituximab for refractory cases
- Caplacizumab if available
- AVOID platelets unless life-threatening bleeding

---

## Gastrointestinal Emergencies

### Upper GI Bleeding

**Risk Stratification - Glasgow-Blatchford:**
| Parameter | Points |
|-----------|---------|
| BUN 18.2-22.4 | 2 |
| BUN 22.4-28 | 3 |
| BUN 28-70 | 4 |
| BUN >70 | 6 |
| Hgb (men) 12-13 | 1 |
| Hgb (men) 10-12 | 3 |
| Hgb (men) <10 | 6 |
| SBP 100-109 | 1 |
| SBP 90-99 | 2 |
| SBP <90 | 3 |
| Pulse ≥100 | 1 |
| Melena | 1 |
| Syncope | 2 |
| Hepatic disease | 2 |
| Heart failure | 2 |

**Score 0 = Low risk, consider discharge**

**Management:**
1. **Resuscitation:**
   - 2 large bore IVs
   - Type & cross
   - Target Hgb 7-8 (9 if CAD)
   - Platelets if <50K
   - FFP if INR >1.5

2. **Medical therapy:**
   - PPI: Pantoprazole 80mg IV → 8mg/hr
   - Octreotide 50mcg bolus → 50mcg/hr (if variceal)
   - Ceftriaxone 1g daily (if cirrhotic)
   - Erythromycin 250mg IV (promotility)

3. **Endoscopy timing:**
   - Urgent (<12h): Hemodynamic instability
   - Early (<24h): Most patients
   - Elective: Low risk patients

### Acute Pancreatitis

**Diagnosis (2 of 3):**
- Abdominal pain consistent with pancreatitis
- Lipase >3x ULN
- Imaging findings

**Severity Scores:**
- BISAP ≥3 = severe
- Ranson ≥3 = severe
- APACHE II >8 = severe

**Management:**
1. **Fluids:** LR 5-10mL/kg/hr initially
   - Goal UOP >0.5mL/kg/hr
   - Decrease BUN
   
2. **Pain:** Multimodal approach
   - Acetaminophen scheduled
   - Opioids PRN
   
3. **Nutrition:** 
   - Oral feeds ASAP if tolerated
   - NG feeds if cannot take PO
   - Avoid TPN if possible

4. **Antibiotics:** Only if infected necrosis

**Complications:**
- Pseudocyst (>4 weeks)
- Necrosis (sterile vs infected)
- Splenic vein thrombosis
- ARDS

---

## Renal Emergencies

### Acute Kidney Injury

**KDIGO Classification:**

| Stage | Creatinine | Urine Output |
|-------|------------|--------------|
| 1 | ↑ 0.3 in 48h or 1.5-1.9x baseline | <0.5mL/kg/hr x6-12h |
| 2 | 2-2.9x baseline | <0.5mL/kg/hr x≥12h |
| 3 | 3x baseline or ≥4.0 or RRT | <0.3mL/kg/hr x≥24h or anuria x12h |

**Workup:**
```
History/Physical
├── Volume status
├── Medications (NSAIDs, ACE-I, contrast)
└── Obstruction signs

Labs:
├── BMP, CBC, LFTs
├── Urinalysis with microscopy
├── Urine electrolytes
└── Renal ultrasound

Urine Findings:
├── Muddy brown casts → ATN
├── WBC casts → AIN, pyelonephritis
├── RBC casts → GN
└── Crystals → Stones, tumor lysis
```

**Management by Type:**

**Pre-renal:**
- Volume resuscitation
- Hold nephrotoxins
- Monitor UOP

**Intrinsic:**
- ATN: Supportive care
- AIN: Consider steroids
- GN: Nephrology consult

**Post-renal:**
- Foley catheter
- Urology consult
- Post-obstruction diuresis

**Dialysis Indications (AEIOU):**
- Acidosis (pH <7.1)
- Electrolytes (K+ >6.5)
- Intoxication
- Overload (pulmonary edema)
- Uremia (pericarditis, encephalopathy)

### Rhabdomyolysis

**Diagnosis:**
- CK >5x normal (typically >5000)
- Myoglobinuria
- ± AKI

**Management:**
1. **Aggressive fluids:**
   - NS 1-2L/hr initially
   - Goal UOP 200-300mL/hr
   
2. **Alkalization (controversial):**
   - If pH <6.5 and CK >6000
   - Bicarb drip to urine pH >6.5
   
3. **Monitor:**
   - CK q6-12h
   - Electrolytes q6h
   - Calcium (avoid unless symptomatic)

4. **Dialysis if:**
   - Refractory hyperkalemia
   - Severe acidosis
   - Volume overload

---

## Quick Reference Cards

### Vasopressor Selection Guide

| Drug | Dose Range | Receptors | Use For |
|------|------------|-----------|---------|
| Norepinephrine | 0.01-3 mcg/kg/min | α>β1 | First-line for septic shock |
| Epinephrine | 0.01-1 mcg/kg/min | α=β | Anaphylaxis, refractory shock |
| Vasopressin | 0.03 units/min | V1 | Adjunct in septic shock |
| Phenylephrine | 0.1-5 mcg/kg/min | α | Pure vasoconstriction |
| Dopamine | 2-20 mcg/kg/min | DA→β→α | Avoid (↑ mortality) |
| Dobutamine | 2.5-20 mcg/kg/min | β1>β2 | Cardiogenic shock |
| Milrinone | 0.125-0.75 mcg/kg/min | PDE-III | Cardiogenic + pulm HTN |

### Antibiotic Quick Guide

**Gram-Positive Coverage:**
- MSSA: Cefazolin, Nafcillin
- MRSA: Vancomycin, Linezolid, Daptomycin
- Enterococcus: Ampicillin, Vancomycin
- VRE: Linezolid, Daptomycin

**Gram-Negative Coverage:**
- E. coli/Klebsiella: Ceftriaxone, FQ
- Pseudomonas: Cefepime, Pip-tazo, Meropenem
- ESBL: Carbapenem
- CRE: Consult ID

**Anaerobic Coverage:**
- Metronidazole
- Beta-lactam/beta-lactamase inhibitors
- Carbapenems

### Code Status Quick Reference

**Full Code:**
- All resuscitative measures
- Default if not specified

**DNR/DNI:**
- No CPR/intubation
- Other treatments continue

**Comfort Care:**
- Symptom management only
- No life-prolonging measures

**Limited Code:**
- Specific interventions only
- Document clearly

---

## Navigation Index

### By Symptom
[Chest Pain](#chest-pain-pathway) | [Dyspnea](#dyspnea-pathway) | [Altered Mental Status](#altered-mental-status) | [Hypotension](#shock-pathway) | [Fever](#fever-pathway) | [Abdominal Pain](#gi-emergencies) | [Bleeding](#hematologic-emergencies)

### By System
[Cardiac](#cardiovascular-emergencies) | [Respiratory](#respiratory-emergencies) | [Neurologic](#neurological-emergencies) | [Renal](#renal-emergencies) | [GI](#gastrointestinal-emergencies) | [Hematologic](#hematologic-emergencies) | [Endocrine](#metabolic-emergencies)

### By Urgency
[Code Blue](#cardiac-arrest) | [Rapid Response](#rapid-response-team-protocols) | [STEMI](#stemi-protocol) | [Stroke Alert](#stroke-tia) | [Massive Transfusion](#massive-transfusion-protocol)

---

[← Back to Main Document](./RapidResponseCentral_NetworkedProtocols.md) | [Top](#rapid-response-central-detailed-protocol-appendix)